Skip to main content
Caplight Logo









Rosebud Biosciences

Rosebud Biosciences

Private
San Carlos, CaliforniaHealthcare & Life Scienceshttps://rosebudbiosci.com/

Last Round

Grant

Aug 15, 2023

Total Funding Raised

$775,000

Company Overview

Rosebud Biosciences is a biotechnology company that develops therapies for rare genetic diseases by modeling human development with patient-specific organoids.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

organoid platformdrug discoverypatient-specific organoidsdisease modelinghigh-throughput screeninglab-on-a-chipprecision medicineautomated biologybio-CROrare disease researchAI drug discovery3D tissue modelingcontract research organizationCROin vitro models

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rosebud Biosciences Comparables

Compare Rosebud Biosciences with similar companies based on industry and business-model similarity.

Rosebud Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Herophilus
82%
Vivodyne
78%
HeartBeat.bio AG
77%

Rosebud Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 15, 2023
AcceleratorMar 29, 2022

Key People

Founding team and executive leadership

Evan Lyall

Co-founder and CTO

Founding Team

Kitch Wilson

Co-founder and CEO

Founding Team

Rosebud Biosciences Investors

Notable investors and investment history

Rosebud Biosciences investors
InvestorRounds
Y CombinatorAccelerator
National Center for Advancing Translational SciencesGrant
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 15, 2023

    $275K raised from National Science Foundation and others.

  • Mar 29, 2022

    $500K round led by Y Combinator

Rosebud Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rosebud Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rosebud Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Carlos, California
Employee Range3
Year Founded2020
Last FundingAug 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?